Cargando…
Effect of Glucose or Fat Challenge on Aspirin Resistance in Diabetes
Aspirin has lower antiplatelet activity in diabetic patients. Our aim is to study the roles of acute hyperglycemia and hyperlipidemia on aspirin function in diabetic subjects with and without cardiovascular disease. Using urine thromboxane (pg/mg creatinine) and VerifyNow (Aspirin Resistance Measure...
Autores principales: | Yassine, Hussein N., Davis-Gorman, Grace, Stump, Craig S., Thomson, Stephen S., Peterson, Justin, McDonagh, Paul F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034931/ https://www.ncbi.nlm.nih.gov/pubmed/21318184 http://dx.doi.org/10.1155/2010/820876 |
Ejemplares similares
-
Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular disease
por: Tuttle, Hillary A, et al.
Publicado: (2003) -
Is sustainable marketing based on virtue ethics the answer to addressing socio-ecological challenges facing humankind?
por: Prothero, Andrea, et al.
Publicado: (2021) -
Aspirin and clopidogrel resistance: methodological challenges and opportunities
por: Gasparyan, Armen Yuri
Publicado: (2010) -
A study of the value of requesting information from drug manufacturers for systematic reviews; 9 years of experience from the drug effectiveness review project
por: McDonagh, Marian S., et al.
Publicado: (2018) -
A Systematic Review of PCSK9 Inhibitors Alirocumab and Evolocumab
por: McDonagh, Marian, et al.
Publicado: (2016)